Cellular and humoral immunity to SARS‐CoV‐2 infection in multiple sclerosis patients on ocrelizumab and other disease‐modifying therapies: a multi‐ethnic …

…, Y Patskovsky, R Curtin, J Pei, K Perdomo… - Annals of …, 2022 - Wiley Online Library
Objective The objective of this study was to determine the impact of multiple sclerosis (MS)
disease‐modifying therapies (DMTs) on the development of cellular and humoral immunity to …

[HTML][HTML] Temporal eating patterns and eating windows among adults with overweight or obesity

…, C Wang, M Prasad, K Fine, A Gee, N Nair, K Perdomo… - Nutrients, 2021 - mdpi.com
We aim to describe temporal eating patterns in a population of adults with overweight or
obesity. In this cross-sectional analysis, data were combined from two separate pilot studies …

Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies

I Kister, R Curtin, J Pei, K Perdomo… - Annals of Clinical …, 2022 - Wiley Online Library
Objective To compare “hybrid immunity” (prior COVID‐19 infection plus vaccination) and
post‐vaccination immunity to SARS CoV‐2 in MS patients on different disease‐modifying …

Challenges of conducting a remote behavioral weight loss study: lessons learned and a practical guide

…, CJ Popp, AY Kharmats, M Curran, K Perdomo… - Contemporary clinical …, 2021 - Elsevier
Objectives To describe challenges and lessons learned in conducting a remote behavioral
weight loss trial. Methods The Personal Diet Study is an ongoing randomized clinical trial …

Food insecurity (FI) in colleges and universities: a needs assessment of student population

E Jesch, C Colgan, K Perdomo… - … Journal of Health …, 2021 - search.proquest.com
Food insecurity (FI) is a public health issue that affects the general public with low income
on a regular basis. In recent years, it is apparent that FI also exists among college students …

Humoral and Cellular Responses to SARS-CoV-2 Vaccines in MS Patients on Ocrelizumab and Other Disease-modifying Therapies: A Prospective Study From NYU …

…, Y Patskovsky, R Curtin, I Voloshyna, K Perdomo… - 2022 - AAN Enterprises
Objective: To compare humoral and cellular responses to COVID-19 vaccines in 400 consecutive
MS patients who were on Ocrelizumab (‘OCR’) and other disease-modifying therapies (…

Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies (preprint)

I Kister, R Curtin, J Pei, K Perdomo, TE Bacon… - 2022 - pesquisa.bvsalud.org
Objective: To compare'hybrid immunity'(prior COVID-19 infection plus vaccination) and post-vaccination
immunity to SARS CoV-2 in MS patients on different disease-modifying …

Prescribing Medications for Chronic Pain Management: The State of Education in Florida Medical Schools and Residency Programs

WA Bonnett, K Perdomo, SC Baker… - Florida Public Health …, 2019 - digitalcommons.unf.edu
The purpose of this study was to assess the state of chronic, non-cancer pain management
education in Florida medical schools and residency programs. Surveys were developed and …

[PDF][PDF] Prescribing medications for chronic pain management: the state of education in Florida medical schools and residency programs.

WA Bonett, K Perdomo, SC Baker, MB Kapp - Florida Public Health Review, 2017 - ut.edu
The purpose of this study was to assess the state of chronic, non-cancer pain management
education in Florida medical schools and residency programs. Surveys were developed and …

[CITATION][C] A MOBILE HEALTH-BASED WEIGHT LOSS PROGRAM: LESSONS LEARNED AND IMPLICATIONS FOR BEHAVIORAL RESEARCH IN THE COVID-19 …

…, M Curran, S Chen, K Perdomo… - Annals of …, 2021 - pesquisa.bvsalud.org
A MOBILE HEALTH-BASED WEIGHT LOSS PROGRAM: LESSONS LEARNED AND
IMPLICATIONS FOR BEHAVIORAL RESEARCH IN THE COVID-19 ERA | Annals of Behavioral …